background image

Paid Clinical Trials Charlotte

Discover 623 paid clinical trials in Charlotte, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

for
Relapsing Multiple Sclerosis (RMS)
Location: 61 recruiting locations
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06869785

Phase3, Recruiting
Active & Responsive

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

for
Non-Hodgkin Lymphoma
Location: 6 recruiting locations
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT05169515

Phase1, Recruiting
Active & Responsive

Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD

for
Rheumatoid Arthritis
Location: 1 recruiting location
Sponsor: Aqtual, Inc.

Sex: All

Age: 18+

Code: NCT05936970

Recruiting
Active & Responsive

Nephrotic Syndrome Study Network

for
Minimal Change Disease (MCD), Membranous Nephropathy,
Location: 24 recruiting locations
Sponsor: University of Michigan

Sex: All

Age: 0 - 70+

Code: NCT01209000

Recruiting
Active & Responsive

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

for
Metastatic Breast Cancer
Location: 54 recruiting locations
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 65+

Code: NCT06377852

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: 41 recruiting locations
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting
Active & Responsive

Esprit BTK Post-Approval Study

for
Chronic Limb-Threatening Ischemia
Location: 28 recruiting locations
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT06656364

Recruiting
Active & Responsive

Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)

for
Knee Pain Chronic, Osteoarthritis, Knee, Rheumatoid Arthritis,
Location: 14 recruiting locations
Sponsor: Zimmer Biomet

Sex: All

Age: 18+

Code: NCT05787821

Recruiting
Active & Responsive

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

for
Systemic Lupus Erythematosus
Location: 37 recruiting locations
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06411249

Recruiting
Active & Responsive

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

for
Relapsed/Refractory Multiple Myeloma
Location: 15 recruiting locations
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05722418

Phase1, Recruiting